CURE Childhood Cancer, Inc.   Report issue

Foundation Phase 1 Phase 2
Founded: Atlanta GA United States (1975)

Organization Overview

First Clinical Trial
2012
NCT01576692
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CURE Childhood Cancer, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma, Clear Cell (Phase 1)

Adenomyoepithelioma (Phase 1)

Astrocytoma (Phase 2)

Brain Neoplasms (Phase 1)

Carcinoma (Phase 1)

Digestive System Neoplasms (Phase 1)

Gastrointestinal Neoplasms (Phase 1)

Glioma (Phase 2)

Lymphoma (Phase 1)

Medulloblastoma (Phase 1)

Neoplasms (Phase 1)

Neuroblastoma (Phase 2)

Optic Nerve Glioma (Phase 2)

Rhabdoid Tumor (Phase 1)

Rhabdomyosarcoma (Phase 1)

Sarcoma, Ewing (Phase 1)

Wilms Tumor (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 22